Molecular and Cellular Pharmacology, Vol 2, No 3 (2010)

The “Two faces” of Tumor Suppressor p53-revisited

Abstract

About 15 years ago, several groups including ours had used matched pairs of cell lines carrying wild type or mutant p53 genes to ascertain a role for p53 in cell survival. These were isogenic cell lines differing only by p53 status. The trend at that time was to support p53-mediated apoptosis. Accordingly, p53-wildtype cells were sensitive to DNA damage compared to p53-mutant cells which were thought to evade apoptosis. However, this finding was not universal. In particular, after UV-radiation, p53-mutant cells were more sensitive than their wild type p53 counterparts in several studies. The finding that p53 controlled a major DNA repair pathway, nucleotide excision repair (NER) which repairs UV-damage, provided a mechanism for the observations. We coined the term "the two faces of tumor suppressor p53" to illustrate that p53 can on one hand induce apoptosis leading to cell sensitivity, but p53 can also enhance the rate of DNA repair thereby protecting cells from DNA damage. This concept has gained acceptance and has been expanded to other DNA-damaging agents. New insights into how p53 is "switched" from a protective function to an apoptotic function are reviewed.

Keywords: DNA-repair; DNA-damage protection

Full Text: PDF (HHS Public Access Author Manuscript, originally deposited in PubMed Central, PMCID: PMC2913486)

This PDF is an author manuscript made publicly available through the NIH Public Access Policy and originally deposited in PubMed Central. All rights remain with the copyright holder.